One experimental drug that has been developed may be the answer for patients affected by inflammatory bowel disease that have been unresponsive to current medications. The drug is known as vedolizumab and is being developed to treat two forms of IBD – ulcerative colitis and Crohn’s Disease.
Both of these diseases occur in the digestive tract and can lead to chronic inflammation, abdominal cramps, diarrhea, and rectal bleeding. During new trials, researchers have discovered that vedolizumab had succeeded in cases where standard medications have been ineffective.
The drug was reported to be more effective for colitis than for Crohn’s. The drug may receive FDA approval for the treatment of colitis first. This is a potential new solution for the 2,000 patients that have either colitis or Crohn’s and have failed to see improvements from standard medications.
During a single trial, 47 percent of a group of 900 colitis patients given vedolizumab infusions reported a decrease in symptoms.
Fresh breath is often associated with brushing, mouthwash, and mints... But sometimes, recurring bad breath can be a sign that something deeper may need attention. Your digestive health can influence how you feel every day. Pay attention if you’re also experiencing:...
Treating symptoms without finding the cause? Many people spend years managing digestive discomfort without understanding what’s really happening. You may temporarily relieve symptoms, but recurring issues can be frustrating when the underlying cause isn’t addressed....
Many people live with bloating, stomach discomfort, acid reflux, or irregular digestion for so long that they start thinking it’s "normal." But hey, just because it’s common doesn’t mean it should be ignored. Your digestive system plays a big role in how you feel...
(310) 855-0222
Fax: (949) 404-6467
Mon - Fri: 9am – 5pm
Sat - Sun: Closed